94 related articles for article (PubMed ID: 8241363)
1. Neuropeptide Y increases force development through a mechanism that involves calcium entry in resistance arteries.
Andriantsitohaina R; Bian K; Stoclet JC; Bukoski RD
J Vasc Res; 1993; 30(6):309-14. PubMed ID: 8241363
[TBL] [Abstract][Full Text] [Related]
2. Effects of noradrenaline and neuropeptide Y on rat mesenteric microvessel contraction.
Chen H; Fetscher C; Schäfers RF; Wambach G; Philipp T; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):314-23. PubMed ID: 8692287
[TBL] [Abstract][Full Text] [Related]
3. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
[TBL] [Abstract][Full Text] [Related]
4. Role of endothelium on the effects of neuropeptide Y in mesenteric resistance arteries of spontaneously hypertensive and Wistar-Kyoto normotensive rats.
Andriantsitohaina R; Stoclet JC; Bukoski RD
J Pharmacol Exp Ther; 1991 Apr; 257(1):276-81. PubMed ID: 2019991
[TBL] [Abstract][Full Text] [Related]
5. Selective potentiation of extracellular Ca2+-dependent contraction by neuropeptide Y in rabbit mesenteric arteries.
Oshita M; Kigoshi S; Muramatsu I
Gen Pharmacol; 1989; 20(3):363-7. PubMed ID: 2545512
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action.
Wahlestedt C; Edvinsson L; Ekblad E; Håkanson R
J Pharmacol Exp Ther; 1985 Sep; 234(3):735-41. PubMed ID: 3928874
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control.
Pernow J; Saria A; Lundberg JM
Acta Physiol Scand; 1986 Feb; 126(2):239-49. PubMed ID: 3010640
[TBL] [Abstract][Full Text] [Related]
8. Possible mechanisms underlying the midazolam-induced relaxation of the noradrenaline-contraction in rabbit mesenteric resistance artery.
Shiraishi Y; Ohashi M; Kanmura Y; Yamaguchi S; Yoshimura N; Itoh T
Br J Pharmacol; 1997 Jul; 121(6):1155-63. PubMed ID: 9249252
[TBL] [Abstract][Full Text] [Related]
9. Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats.
Gradin KA; Li JY; Andersson O; Simonsen U
J Vasc Res; 2003; 40(3):252-65. PubMed ID: 12902638
[TBL] [Abstract][Full Text] [Related]
10. Interactions between neuropeptide Y and the adenylate cyclase pathway in rat mesenteric small arteries: role of membrane potential.
Prieto D; Buus C; Mulvany MJ; Nilsson H
J Physiol; 1997 Jul; 502 ( Pt 2)(Pt 2):281-92. PubMed ID: 9263910
[TBL] [Abstract][Full Text] [Related]
11. Influence of extracellular calcium and nifedipine on alpha 1- and alpha 2-adrenoceptor-mediated contractile responses in isolated rat and cat cerebral and mesenteric arteries.
Skärby T; Högestätt ED; Andersson KE
Acta Physiol Scand; 1985 Apr; 123(4):445-56. PubMed ID: 2859736
[TBL] [Abstract][Full Text] [Related]
12. Effect of propofol on norepinephrine-induced increases in [Ca2+]i and force in smooth muscle of the rabbit mesenteric resistance artery.
Imura N; Shiraishi Y; Katsuya H; Itoh T
Anesthesiology; 1998 Jun; 88(6):1566-78. PubMed ID: 9637651
[TBL] [Abstract][Full Text] [Related]
13. Calcium-contraction relationship in rat mesenteric arterial smooth muscle. Effects of exogenous and neurogenic noradrenaline.
Raat NJ; Wetzels GE; De Mey JG
Pflugers Arch; 1998 Jul; 436(2):262-9. PubMed ID: 9594027
[TBL] [Abstract][Full Text] [Related]
14. Endothelium-independent potentiating effects of neuropeptide Y in the rat tail artery.
Small DL; Bolzon BJ; Cheung DW
Eur J Pharmacol; 1992 Jan; 210(2):131-6. PubMed ID: 1318205
[TBL] [Abstract][Full Text] [Related]
15. Differences in Ca2+ handling along the arterial tree: an update including studies in human mesenteric resistance vessels.
Cauvin C; Weir SW; Bühler FR
J Cardiovasc Pharmacol; 1988; 12 Suppl 6():S10-5. PubMed ID: 2468888
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide-Y enhances luteinizing hormone (LH)-releasing hormone-induced LH release and elevations in cytosolic Ca2+ in rat anterior pituitary cells: evidence for involvement of extracellular Ca2+ influx through voltage-sensitive channels.
Crowley WR; Shah GV; Carroll BL; Kennedy D; Dockter ME; Kalra SP
Endocrinology; 1990 Sep; 127(3):1487-94. PubMed ID: 1696888
[TBL] [Abstract][Full Text] [Related]
17. Characterization of two different calcium entry pathways in small mesenteric arteries from rat.
Högestätt ED
Acta Physiol Scand; 1984 Dec; 122(4):483-95. PubMed ID: 6098138
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of Ca2+ release and entry during contraction elicited by norepinephrine in rat resistance arteries.
Lagaud GJ; Randriamboavonjy V; Roul G; Stoclet JC; Andriantsitohaina R
Am J Physiol; 1999 Jan; 276(1):H300-8. PubMed ID: 9887044
[TBL] [Abstract][Full Text] [Related]
19. The mechanisms of the direct action of etomidate on vascular reactivity in rat mesenteric resistance arteries.
Shirozu K; Akata T; Yoshino J; Setoguchi H; Morikawa K; Hoka S
Anesth Analg; 2009 Feb; 108(2):496-507. PubMed ID: 19151278
[TBL] [Abstract][Full Text] [Related]
20. Actions of calcium antagonists on pre- and postjunctional effects of neuropeptide Y on human peripheral blood vessels in vitro.
Pernow J; Svenberg T; Lundberg JM
Eur J Pharmacol; 1987 Apr; 136(2):207-18. PubMed ID: 3595720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
